IHAM

Integral Health Asset Management Portfolio holdings

AUM $1.97B
1-Year Est. Return 106.57%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+106.57%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.97B
AUM Growth
+$601M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
97
New
Increased
Reduced
Closed

Top Buys

1
+$52.5M
2
+$51M
3
+$45.3M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$37.4M
5
DXCM icon
DexCom
DXCM
+$32.3M

Top Sells

1
+$63.9M
2
+$40.4M
3
+$30.1M
4
BTSG icon
BrightSpring Health Services
BTSG
+$13.4M
5
PFE icon
Pfizer
PFE
+$12.7M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GPCR icon
76
Structure Therapeutics
GPCR
$4.12B
$3.48M 0.18%
+50,000
SGHT icon
77
Sight Sciences
SGHT
$212M
$3.37M 0.17%
+425,000
GOSS icon
78
Gossamer Bio
GOSS
$117M
$3.1M 0.16%
+1,000,000
OSCR icon
79
Oscar Health
OSCR
$3.96B
$2.87M 0.15%
200,000
-350,000
LBRX
80
LB Pharmaceuticals
LBRX
$608M
$2.23M 0.11%
100,000
EVMN
81
Evommune Inc
EVMN
$757M
$2.14M 0.11%
+125,000
TENX icon
82
Tenax Therapeutics
TENX
$90.6M
$2.04M 0.1%
167,000
TNGX icon
83
Tango Therapeutics
TNGX
$2.22B
$1.77M 0.09%
+200,000
BCRX icon
84
BioCryst Pharmaceuticals
BCRX
$2.19B
$1.56M 0.08%
+200,000
A icon
85
Agilent Technologies
A
$32.6B
– –
-90,000
ACHC icon
86
Acadia Healthcare
ACHC
$2.32B
– –
-300,000
DYN icon
87
Dyne Therapeutics
DYN
$3.26B
– –
-800,000
ESPR icon
88
Esperion Therapeutics
ESPR
$645M
– –
-1,500,000
EXAS icon
89
Exact Sciences
EXAS
$19.7B
– –
-200,000
HOLX icon
90
Hologic
HOLX
$16.9B
– –
-100,000
IQV icon
91
IQVIA
IQV
$29B
– –
-45,000
JNJ icon
92
Johnson & Johnson
JNJ
$587B
– –
-30,000
MCK icon
93
McKesson
MCK
$114B
– –
-15,000
NAMS icon
94
NewAmsterdam Pharma
NAMS
$3.6B
– –
0
NVO icon
95
Novo Nordisk
NVO
$172B
– –
0
PFE icon
96
Pfizer
PFE
$154B
– –
-500,000
PHVS icon
97
Pharvaris
PHVS
$1.68B
– –
-200,000
1 2 3
4